Caring for patients with chronic lymphocytic leukemia

Clinical Journal of Oncology Nursing

Volumn 12, Issue 3, 2008, Pages 417-423

  Elphee, Erin E ^a  

^a CANCERCARE MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; B CELL LEUKEMIA; CANCER STAGING; DEPRESSION; FATIGUE; HEALTH SERVICE; HUMAN; INCIDENCE; INFECTION; NURSE ATTITUDE; NURSING ASSESSMENT; ONCOLOGY NURSING; ORGANIZATION AND MANAGEMENT; PATIENT CARE PLANNING; PATIENT EDUCATION; PHILOSOPHY; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; RISK FACTOR; SOCIAL SUPPORT; SURVIVAL RATE;

ANXIETY; DEPRESSION; FATIGUE; HEALTH SERVICES NEEDS AND DEMAND; HOLISTIC HEALTH; HUMANS; INCIDENCE; INFECTION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; NEOPLASM STAGING; NURSE'S ROLE; NURSING ASSESSMENT; ONCOLOGIC NURSING; PATIENT CARE PLANNING; PATIENT EDUCATION AS TOPIC; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS; SOCIAL SUPPORT; SURVIVAL RATE;

EID: 49849090540     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/08.CJON.417-423     Document Type: Article

References (36)

1. Abbott, B.L. (2006). Chronic lymphocytic leukemia: Recent advances in diagnosis and treatment. Oncologist, 11(1), 21-30.
2. Banerji, V., Demers, A., Johnston, J.B., Pitz, M., Nugent, Z., Morales, C., et al. (2006). Younger patients with CLL/SLL are less frequent and have favorable survival in a Canadian population based study: The Manitoba cohort [Abstract]. Blood, 108(11).
3. Bertero, C., & Erikkson, B.E. (1997). Explaining different profiles in quality of life experiences in acute and chronic leukemia. Cancer Nursing, 20(2), 100-104.
4. Binet, J.L., Calligaris, F., Catovsky, D., Cheson, B., Davis, T., Dighiero, G., et al. (2006). Perspectives on the use of new diagnostic tools in the treatment of CLL. Blood, 107(3), 859-861.
5. Breed, C. (2003). Diagnosis, treatment and nursing care of patients with chronic leukemia. Seminars in Oncology, 19(2), 109-117.
6. Chapel, H.M., & Bunch, C. (1987). Mechanisms of infection in chronic lymphocytic leukemia. Seminars in Hematology, 24(4), 291-296.
7. de Lima, M., O'Brien, S., Lerner, S., & Keating, M. J. (1998). Chronic lymphocytic leukemia in the young patient. Seminars in Oncology, 25(1), 107-116.
8. Dighiero, G., & Binet, J.L. (2000). When and how to treat chronic lymphocytic leukemia. New England Journal of Medicine, 343(24), 1799-1801.
9. Esteve, J., Villamor, N., Colomer, D., Cervantes, F., Campo, E. Carreras, E., et al. (2001). Stem cell transplantation for chronic lymphocytic leukemia: Different outcome after autologous transplantation and correlation with minimal residual status. Leukemia, 15(3), 445-451.
10. Faguet, G.B. (1994). CLL: An updated review. Journal of Clinical Oncology, 12(9), 1974-1990.
11. Graydon, J.E., Bubela, N., Irvine, D., & Vincent, L. (1995). Fatigue-reducing strategies used by patients receiving treatment for cancer. Cancer Nursing, 18(1), 23-28.
12. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., et al. (1999). World Health Organization classification of neoplastic diseases of the hematopoeitic and lymphoid tissue: Report of the Clinical Advisory Committee meeting-Airline House, Virginia. Journal of Clinical Oncology, 17 (12), 3835-3849.
13. Hays, H., & McCartney, S. (1998). Nursing care of the patients with chronic lymphocytic leukemia. Seminars in Oncology, 25(1), 75-79.
14. Hensel, M., Kornacker, M., Yammeni, S., Egerer, G., & Ho, A.D. (2003). Disease activity and pretreatment, rather than hypogam-maglobulinemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukemia. British Journal of Haematology, 122(4), 600-606.
15. Holzner, K., Koppe, M., Nguyen-Van-Tam, D., Sperner, G., & Greil, R. (2004). Quality of life of patients with CLL: Results of a longitudinal investigation over 1 year. European Journal of Haematology, 72(6), 381-389.
16. Houlston, R.S., Catovsky, D., & Yuille, M.R. (2002). Genetic susceptibility to chronic lymphocytic leukemia. Leukemia, 16(6), 1008-1014.
17. Keating, M.J., Kantarjian, H., O'Brien, S., Koller, C., Talpaz, M., Schachner, J., et al. (1991). Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. Journal of Clinical Oncology, 9(1), 44-49.
18. Khouri, I.F., Keating, M.J., Saliba, R.M., & Champlin, R.E. (2002). Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation. Cytotherapy, 4(3), 217-221.
19. Levin, T.T., Li, Y., Riskind, J., & Rai, K. (2007). Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort, General Hospital Psychiatry, 29(3), 251-256.
20. Lynn, A.L., Williams, M.L., Sickler, J., & Burgess, S. (2003). Treatment of chronic lymphocytic leukemia with alemtuzumab: A review for nurses. Oncology Nursing Forum, 30(4), 689-694.
21. Mandrell, B. (2004). Leukemia. In C.G. Varricchio (Ed.), A cancer source book for nurses (8th ed., pp. 251-263). Philadelphia: Jones and Bartlett.
22. Mishel, M.H., Hostetter, T., King, B., & Graham, V. (1984). Predictors of psychosocial adjustment in patients newly diagnosed with gynecological cancer. Cancer Nursing, 1(4), 291-299.
23. Molica, S. (2005). Quality of life in chronic lymphocy tic leukemia: A neglected issue. Leukemia and Lymphoma, 46(12), 1709-1714.
24. Montgomery, C., Popcock, M., Titley, K., & Lloyd K. (2002). Individual quality of life in patients with leukemia and lymphoma. Psycho-Oncology, 11(3), 239-243.
25. Morrison, V. (1998). The infectious complications of chronic lymphocytic leukemia. Seminars in Oncology, 25(1), 98-106.
26. Oscier, D., Fegan, C., Hillmen, P., Illidge, T., Johnson, S., Maguire, P., et al. (2004). Guidelines in the diagnosis and management of CLL. British Journal of Haematology, 125(3), 294-317.
27. Palma, M., Kokhaei, P., Lundin, J., Choudhury, A., Mellstedt, H., & Osterborg, A. (2006). The biology and treatment of chronic lym-phocytic leukemia. Annals of Oncology, 17(Suppl. 10), 144-154.
28. Rai, K.R., Peterson, B.L., Applebaum, F.R., Kolitz, J., Elias, L., Shepherd, L., et al. (2000). Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. New England Journal of Medicine, 343(24), 1750-1757.
29. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N., & Pasternak, B.S. (1975). Clinical staging of CLL. Blood, 46(2), 219-234.
30. Redaelli, A., Laskin, B.L., Stephens, J.M., Botteman, M.F., & Pashos, C.L. (2004). The clinical and epidemiological burden of chronic lympho-cytic leukemia. European Journal of Cancer Care, 13(3), 279-287.
31. Rozman, C., Montserrat, E., & Vinolas, N. (1988). Serum immunoglobulins in B-chronic lymphoid leukemias. Natural history and prognostic significance. Cancer, 61(2), 279-283.
32. Shanafelt, T.D., & Call, T.G. (2004). Current approach to diagnosis and management of chronic lymphocytic leukemia. Mayo Clinic Proceedings, 79(3), 388-398.
33. Wierda, W.G. (2006). Current and investigational therapies for patients with CLL. Hematology/The Education Program of the American Society of Hematology, 285-294.
34. Yee, K.W., & O'Brien, S.M. (2006). CLL: Diagnosis and treatment. Mayo Clinical Proceedings, 81(8), 1105-1129.
35. Yuille, M.R., Houlston, R.S., & Catovsky, D. (1998). Anticipation in familial CLL. Leukemia, 12(11), 1696-1698.
36. Yura, H. (1951). Chronic lymphocytic leukemia: A nursing case s t u d y. American Journal of Nursing, 51(5), 345-346.